BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Manufacturing

Samsung Biologics Shares Strategic Roadmap for Sustainable Growth

During the main track presentation today, John Rim, President and CEO of Samsung Biologics, addressed the company's vision for 2022 and business goals...

January 13, 2022 | News

Definitive Agreement to Acquire Exelead will Strengthen Merck’s CDMO Offering for mRNA

Merck, a leading science and technology company, has signed a definitive agreement to acquire Exelead, a biopharmaceutical contract development and manufac...

January 07, 2022 | News

WuXi Biologics, ImmuneOncia Sign MOU for Development and Manufacturing of Anti-PD-L1/CD47 Bispecific Antibody

Within the partnership, ImmuneOncia will have access to WuXi Biologics' integrated services in cell line development, cell culture development, biologics m...

December 28, 2021 | News

Curia Unveils Comprehensive mRNA Solution

Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today unveiled its messenger RNA (mRNA) solution, which incl...

December 27, 2021 | News

Curocell, Breaks Ground on 'CAR-T Manufacturing GMP Facility'

The GMP Facility for commercial manufacturing CAR-T Cell therapy and R&D Center for further pipeline development are constituting the 17,325 square-met...

December 24, 2021 | News

Samsung Biologics adds to global ISO certifications with Quality Management System

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization, held an award ceremony with the British Standa...

December 08, 2021 | News

GenScript ProBio To Expands It's Manufacturing Capacity in China

On December 7th, the "Opening Ceremony of GenScript ProBio Plasmid Commercial GMP Manufacturing facility and Open Day" was rounded off. GenS...

December 08, 2021 | News

Vetter Wins Frost & Sullivan’s 2021 Global Customer Value Leadership Award

Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), has been awarded the Frost & Sullivan’s 2021...

December 07, 2021 | News

First GMP Production at 24,000L Line of MFG5 Facility Successfully Completed at WuXi Biologics

WuXi Biologics (“WuXi Bio”) (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has successf...

November 26, 2021 | News

Amgen and Bushu Pharma Announce Expanded Supply Chain Partnership across Japan and Asia-Pacific Region

Bushu Pharmaceuticals Ltd. ("Bushu Pharma") has agreed on an expanded partnership with Amgen Inc. and Amgen K.K. to provide its "Gateway to Asia" serv...

November 25, 2021 | News

GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing

GreenLight Biosciences (Nasdaq: ENVI), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human heal...